News Image

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

Provided By GlobeNewswire

Last update: Dec 6, 2023

The market for obesity drugs is projected to exceed $77 billion by 2030

Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study

Read more at globenewswire.com

BULLFROG AI HOLDINGS INC

NASDAQ:BFRG (10/17/2025, 8:00:01 PM)

After market: 1.46 -0.01 (-0.68%)

1.47

0 (0%)


BULLFROG AI HOLDINGS INC-28

NASDAQ:BFRGW (10/17/2025, 8:00:01 PM)

0.49

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more